CD8A and non-small cell lung carcinoma: For instance, circIGF2BP3, circFGFR1 and circ-CPA4 could promote immune evasion and inhibit CD8+ T cell response in non-small cell lung cancer by facilitating the PD-L1 expression [45–47].